For instance, cancer cells harboring KRAS mutations have been shown to reprogram cancer cell metabolism towards an increase in uptake and catabolism of amino acids, such as glutamine and tryptophan, with pro-tumoral effects [41,42,43]. The gene discussed is KRAS; the disease is cancer.